Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453

NCT02845037 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Chronic Heart Failure

Interventions

DRUG: BIA 5-453
DRUG: Placebo

Sponsor

Bial - Portela C S.A.